10
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Methylguazone, Vindesine and Cisplatin for the Treatment of Patients with Relapsed or Refractory Malignant Lymphoma: An Eastern Cooperative Oncology Group Study (PA482)

, , , &
Pages 619-624 | Received 12 Dec 1997, Published online: 01 Jul 2009

References

  • Sklaroff R.B., et al. Phase II trial of vindesine in patients with malignant lymphoma. Cancer Treat Rep 1979; 63: 793–794
  • Warrell R.P., Jr., Lee B.J., Kempin S.T., Lacher M.J., Straus D.J., Young C.W. Effectiveness of methyl-GAG (methylglyoxal-bis guanylhydrazone) in patients with advanced malignant lymphoma. Blood 1981; 57: 1011–1014
  • Cavalli F., et al. Phase II trial of cis-dichlorodiammine-platinum (II) in advanced malignant lymphoma: A study of the Cancer and Acute Leukemia Group B. Cancer 1981; 48: 1927–1930
  • Pleshkewych A., Kramer D.L., Kelly E., et al. Independence of drug action on mitochondria and polyamines in L1210 leukemia cells treated with methylglyoxal bis (guanylhydrazone). Cancer Res 1980; 40: 4533–4540
  • Zwelling L.A., Kohn K.W. Mechanism of action of cis-dichlorodiammineplatinum (II). Cancer Treat Rep 1979; 63: 1439–1444
  • Dyke R.W., Nelson R.L. Phase I anti-cancer agents: Vindesine (desacetyl vinblastine amide sulfate). Cancer Treat Rev 1977; 4: 135–142
  • Cox D.R., Oakes F. The Analysis of Survival data. Chapman and Hall, London 1984
  • Owellen R.J., Root M.A., Hains F.O. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res 1977; 37: 2603–2607
  • Freelander B.L., French F.A. Carcinostatic action of polycarbonyl compounds and their derivatives. II Glyoxal bis (Guanylhydrazone) and derivatives. Cancer Res 1958; 18: 360–363
  • Levine A.M., Tulpule A., Tessman D., Kaplan L., Giles F., Luskey B.D., Scadden D.T., Northfelt D.W., Silverberg I., Wernz J., Espina B., Von Hoff D. Mitoguazone therapy in patients with refractory relapsed AIDS-related lymphoma: Results from a multicenter phase II trial. J Clin Oncol 1997; 15: 1094–1103
  • Wiernik P.H., Moore D.F., Bennett J.M., Vogl S.E., Harris J.E., Luger S., Oken M.M., Glick J.H. Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group study (PE481). Leukemia and Lymphoma 1997, in press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.